Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors (clinicaltrialsregister.eu) - May 28, 2026 - P1/2 | N=80 | Recruiting | Sponsor: Grupo Espaol de Trasplantes Hematopoyticos y Terapia Celular | Not yet recruiting ➔ Recruiting
Enrollment open • Cytomegalovirus Infection • Infectious Disease • Transplantation
|